StockWatch
·

Epack Prefab Technologies Ltd Q1 FY27 Results

EPACKPEBQ1 FY27 Results
Filing
Result:Good· Market: CrashedMargin squeezeCost led

Outlook: Cautiously Optimistic · Guidance: Raised

MetricValueChangeQ1 FY26
Revenue365.84 Cr23.9%
Total Income369.60 Cr24.1%
Expenditure345.42 Cr24.9%
PBT24.18 Cr13.4%
Net Profit18.17 Cr13.4%
OPM9.43%1.04pp
NPM4.92%0.46pp
EPS1.8112.6%
View full financials

Industrials: revenue grew a strong 23.9% YoY clearing the 20% guidance floor, but PAT growth lagged at 13.4% as OPM compressed to 9.43% from 10.47% on rising materials cost, so it's healthy top-line-driven growth capped short of very_good by margin quality.

EPACK PREFAB · Q1 FY27 · THE VERDICT

Record order book, margin recovery unproven

EPACK delivered ₹366 Cr revenue (+23.9% YoY) backed by a record ₹1,380 Cr order book, but EBITDA margin slipped to 9.4%—110 bps below guidance. The question now is whether Q2 delivers the promised recovery or reveals a deeper credibility gap.

17 Aug 2026 · 6 min read
Revenue delivered

₹366 Cr

+23.9% YoY

EBITDA margin

9.4%

vs 10.5% guidance

PAT growth

+13.4% YoY

lags revenue +23.9%

EPACK landed Q1 revenue of ₹366 Cr (+23.9% YoY)—broadly in line with stated targets—and backed it with an exceptional ₹1,380 Cr order book that spans 6–8 months of run-rate, supporting the company's upgraded 30% FY27 growth target. That order momentum is real. But the margin picture tells a different story. EBITDA contracted to 9.4%, sitting 110 bps below the 10.5% floor of management's full-year guidance. More telling: PAT grew only 13.4% YoY while revenue grew 23.9%—a 1,050 bps spread that signals the profit leverage isn't there yet.

The margin miss: Commodity shock or structural pressure?

Management attributes the 110 bps Q1 margin dip entirely to commodity price inflation (12–15% steel price swings post-Middle East tensions), a risk they pre-warned in the May call. The explanation is logically sound—EPACK operates on 100% fixed-price contracts with no pass-through mechanism, so sudden input cost spikes hit the P&L directly. But the credibility gap sits in the recovery claim. Management says Q2 onwards will normalize to 10.5%+ because (a) older orders taken at earlier pricing will either have executed or been repriced, and (b) all new orders are booked at current-week spot prices, hedging forward demand.

I think you will start to see improvement in the EBITDA margin from this quarter, second quarter onwards.

Confidence was high, but the bar for proof is also high—only one quarter of data post-shock, and commodity markets remain volatile. If steel prices stay elevated or decline slowly, the recovery will not materialize, and the margin target will miss for the full year.

Management's claims vs. what holds up

Revenue growth about 25% YoY

Delivered 23.9% YoY (₹366 Cr vs ₹295 Cr prior year Q1)

Slightly overstated

EBITDA margin at 9.4%

Confirmed: ₹35 Cr EBITDA on ₹366 Cr revenue = 9.4%

Supported

Margins will normalize to 10.5% from Q2 onwards

Q1 at 9.4% is 110 bps below guidance; recovery contingent on steel price stabilization

Unverified

Largest-ever order ₹165 Cr from renewable company

Confirmed in call; execution on 4.5-month compressed timeline (vs typical 6–8 months)

Supported

Order book 150% growth YoY (₹580 Cr Q1 inflows vs ₹240 Cr prior year)

Stated; internally consistent with ₹1,380 Cr closing order book

Supported

What changed on this call

  • Revenue guidance upgraded from ≥20% minimum to explicit 30% for FY27

  • Backed by ₹1,380 Cr order book and ₹580 Cr Q1 inflows (+150% YoY)

  • EBITDA margin guidance maintained at 10.5–11.5% full-year despite Q1 miss

  • Data center segment launched: ₹75 Cr capex, 4–5% of current order book

  • Lost 2 major data center deals on design and pricing; learning curve acknowledged

The bull-bear ledger

Reasons to be constructive
  • Order book at ₹1,380 Cr spans 6–8 months of visibility; supports growth target

  • Q1 order inflow of ₹580 Cr (+150% YoY) is a structural step-change, not a spike

  • Largest order (₹165 Cr renewable energy) signals new market capture

  • All four manufacturing plants running at 75%+ utilization; capacity expansion underway

  • Market share expanding: 5–6% in FY26 to 7–7.5% by FY27 end

Reasons to be cautious
  • EBITDA margin 110 bps below guidance; PAT growth 13.4% lags revenue 23.9%

  • 100% of orders are fixed-price with no pass-through; weekly repricing doesn't eliminate exposure

  • Win rate only 20%; 80% bid loss rate questions pricing power and competitive position

  • Data center segment nascent: 4–5% of order book, 2 deals lost, facility location undecided

  • Margin recovery unproven: contingent on steel prices stabilizing (external variable)

Ranked risks

Critical concerns for a holder, ranked by impact

Margin recovery credibility

HIGH

Q1 at 9.4% vs 10.5% guidance. Recovery is contingent on steel prices stabilizing, not on EPACK's actions. If commodity inflation persists, the full-year margin target misses and 30% revenue growth becomes much less profitable.

Fixed-price commodity exposure

HIGH

100% of orders are fixed-price with zero pass-through. Weekly repricing hedges future demand but leaves legacy orders vulnerable. If steel prices stay elevated, margin recovery fails; if they crash, competitors undercut EPACK on pricing.

Data center execution

HIGH

Subsidiary capitalized at ₹75 Cr; facility location undecided. Only 4–5% of order book, 2 major deals lost on design and pricing. If execution stalls, capex becomes a drag on ROCE; if it succeeds, it's a multi-year ramp, not a 2-quarter catalyst.

Growth pacing

MEDIUM

Q1 at 23.9% YoY trails the 30% FY27 target. To hit ₹1,950 Cr revenue, run-rate needs ~₹400 Cr per quarter; Q1 was ₹366 Cr. Order book provides visibility, but monsoon delays, execution hiccups, or deal slippage could compress H2.

Win rate and pricing power

MEDIUM

20% win rate (80% loss rate) on only 30–40% of quotations pursued. While selective focus is defensible, the high loss rate could signal pricing power weakness or design gaps vs. competitors in key segments (logistics, autos, data centers).

How the street is positioned

The market's initial reaction was sharp: the stock fell 8.74% on day 1 post-result announcement, faded slightly to -4.32% by day 3, then reopened with fresh selling to -7.86% by day 5. The move reflects disappointment at the margin miss and unproven recovery narrative, even as the order book impressed. At ₹229.7 (as of Aug 14), the stock sits 33% below its all-time high of ₹344—a substantial drawdown that suggests the market has already priced in execution risk and margin headwinds. Against its 20-day and 50-day moving averages (both ~₹248–₹250), the stock trades 7–8% below near-term resistance, and RSI at 37.5 signals neither oversold nor in a confirmed uptrend.

On the ownership front, FII holdings ticked up marginally (+0.2pp to 11.11% in Q1 FY-27 vs 10.91% in Q4 FY-26), suggesting foreign investors are not in headlong retreat, though the uptick is modest. Bulk/block activity over the past six months shows disciplined trading around ₹240–₹265—no promoter or insider-linked selling near the highs, a positive signal. The activity is consistent with normal rebalancing, not panic distribution.

What to watch next

Critical near-term catalysts
  • 1 · Q2 EBITDA margin (Sep 2026)

    The proof point for management's recovery narrative. Guidance is 10.5%+; if it hits, confidence in the full-year target rises. If it stays at 9.4–9.6%, the credibility of the commodity-only explanation erodes and structural margin pressure becomes a concern.

  • 2 · Ghiloth and AP sandwich panel line commissioning (Q2 target)

    Two major capex projects coming online; ramp-up trajectory and first-month utilization will signal execution speed and de-risk the ₹2,700–2,900 Cr long-term revenue target.

  • 3 · Data center deal pipeline (Q2 target)

    MD guided for a data center deal by quarter-end. Booking and margin snapshot on this segment will determine whether the ₹75 Cr capex is a value bet or a value trap.

EPACK is no longer a quiet domestic fabricator. The company is executing at scale—₹366 Cr revenue, ₹1,380 Cr order book, entry into renewable energy and data centers—and the street has already revalued it 33% lower from the highs to price in execution risk and margin volatility. That repricing is not irrational; the margin question is real. But the order book is also real, and 6–8 months of visibility at 30% growth rates is a credible near-term foundation.

The test is Q2: if EBITDA margin bounces to 10.5%, the dip was external and the guidance holds. If it doesn't, the story shifts from temporary commodity shock to structural margin pressure, and the investment case becomes much harder. The number to track from here is the EBITDA margin—revenue will likely hit the ₹400+ Cr quarterly run-rate implied by ₹1,950 Cr FY27 guidance; the real debate is whether the profit margin follows.

Informational and educational content only. Not investment advice.